Suzhou Novoprotein Operating Margin vs. Return On Asset

688137 Stock   37.07  0.26  0.70%   
Considering Suzhou Novoprotein's profitability and operating efficiency indicators, Suzhou Novoprotein Scientific may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Suzhou Novoprotein's ability to earn profits and add value for shareholders.
For Suzhou Novoprotein profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Suzhou Novoprotein to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Suzhou Novoprotein Scientific utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Suzhou Novoprotein's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Suzhou Novoprotein Scientific over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Suzhou Novoprotein's value and its price as these two are different measures arrived at by different means. Investors typically determine if Suzhou Novoprotein is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Suzhou Novoprotein's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Suzhou Novoprotein Return On Asset vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Suzhou Novoprotein's current stock value. Our valuation model uses many indicators to compare Suzhou Novoprotein value to that of its competitors to determine the firm's financial worth.
Suzhou Novoprotein Scientific is number one stock in operating margin category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Suzhou Novoprotein by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Suzhou Novoprotein's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Suzhou Return On Asset vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Suzhou Novoprotein

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
0.58 %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Suzhou Novoprotein

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.0228
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

Suzhou Return On Asset Comparison

Suzhou Novoprotein is currently under evaluation in return on asset category among its peers.

Suzhou Novoprotein Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Suzhou Novoprotein, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Suzhou Novoprotein will eventually generate negative long term returns. The profitability progress is the general direction of Suzhou Novoprotein's change in net profit over the period of time. It can combine multiple indicators of Suzhou Novoprotein, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Net Interest Income26.8 M28.2 M
Interest Income30.5 M32 M
Operating Income-5.9 M-5.6 M
Net Income From Continuing Ops12.8 M12.2 M
Income Before Tax6.2 M5.9 M
Net Income12.8 M12.2 M

Suzhou Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Suzhou Novoprotein. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Suzhou Novoprotein position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Suzhou Novoprotein's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Suzhou Novoprotein without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Theme Ratings Now

   

Theme Ratings

Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Use Investing Themes to Complement your Suzhou Novoprotein position

In addition to having Suzhou Novoprotein in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Synthetics Thematic Idea Now

Synthetics
Synthetics Theme
Companies involved in production of silicon and other synthetic products . The Synthetics theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Synthetics Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Suzhou Stock

To fully project Suzhou Novoprotein's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Suzhou Novoprotein at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Suzhou Novoprotein's income statement, its balance sheet, and the statement of cash flows.
Potential Suzhou Novoprotein investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Suzhou Novoprotein investors may work on each financial statement separately, they are all related. The changes in Suzhou Novoprotein's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Suzhou Novoprotein's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.